![]() Alumis Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies. | ![]() Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. | ![]() Enanta Pharmaceuticals Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule drugs for virology and immunology. | ![]() Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. | ||
Founding Date | Founding Date 2021 | Founding Date 2010 | Founding Date 1966 | Founding Date 1995 | Founding Date 2014 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Francisco, US HQ | Locations Heze, CN HQ | Locations Pune, IN HQ Mumbai, IN Pune, IN | Locations Watertown, US HQ | Locations New Haven, US HQ |
Employees | Employees 107 | Employees 95920% decrease | Employees 5,3831% increase | Employees 1459% decrease | Employees 4343% increase |
Valuation ($) | Valuation ($) 652.3 m | Valuation ($) 708.6 m | Valuation ($) N/A | Valuation ($) 243.7 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $24.1m (FY, 2025) | Revenue (est.) ¥961.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $65.3m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($243.3m) (FY, 2025) | Net income (¥84.7m) (FY, 2025) | Net income N/A | Net income ($81.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 270m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 9.2m | Total funding raised $ 80m |

Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
View company
Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule drugs for virology and immunology.
View company
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
View company